Literature DB >> 17275003

Genetic risk for restenosis after coronary stenting.

Mitsutoshi Oguri1, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Tomonori Segawa, Hitoshi Matsuo, Sachiro Watanabe, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.   

Abstract

OBJECTIVES: The purpose of the present study was to identify gene polymorphisms that confer susceptibility to restenosis after bare-metal stenting of coronary arteries, and thereby to predict the genetic risk for this condition. METHODS AND
RESULTS: The study population comprised 461 unrelated Japanese individuals (350 men, 111 women) who underwent stent implantation, including 107 subjects who developed in-stent restenosis and 354 subjects without this condition. The genotypes for 142 polymorphisms of 121 candidate genes were determined with a method that combines the polymerase chain reaction and sequence-specific oligonucleotide probes with suspension array technology. Multivariate logistic regression analysis with adjustment for the prevalence of diabetes mellitus revealed that the 1615G-->A polymorphism of BCHE, the 7,067,365C-->A polymorphism of INSR, the C-->T polymorphism of GPX1, the G-->A polymorphism of ROS1, and the G-->A polymorphism of MMP9 were associated (P<0.05) with in-stent restenosis. Further analysis with adjustment both for the prevalence of diabetes mellitus and for quantitative coronary angiographic measurements revealed that the BCHE, GPX1, and ROS1 genotypes were independently associated (P<0.05) with in-stent restenosis.
CONCLUSIONS: Determination of the genotypes for BCHE, GPX1, and ROS1 may prove informative for assessment of the genetic risk for in-stent restenosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275003     DOI: 10.1016/j.atherosclerosis.2006.12.019

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

Review 1.  Restenosis after PCI. Part 1: pathophysiology and risk factors.

Authors:  J Wouter Jukema; Jeffrey J W Verschuren; Tarek A N Ahmed; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-09-13       Impact factor: 32.419

Review 2.  Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities.

Authors:  Edith Lubos; Joseph Loscalzo; Diane E Handy
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

Review 3.  Progress in the emerging role of selenoproteins in cardiovascular disease: focus on endoplasmic reticulum-resident selenoproteins.

Authors:  Carmine Rocca; Teresa Pasqua; Loubna Boukhzar; Youssef Anouar; Tommaso Angelone
Journal:  Cell Mol Life Sci       Date:  2019-06-19       Impact factor: 9.261

4.  Progression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II).

Authors:  Andreas W Schoenenberger; Peiman Jamshidi; Richard Kobza; Michel Zuber; Andreas E Stuck; Matthias Pfisterer; Paul Erne
Journal:  Clin Cardiol       Date:  2010-05       Impact factor: 2.882

5.  Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1.

Authors:  Ziad A Ali; Vinicio de Jesus Perez; Ke Yuan; Mark Orcholski; Stephen Pan; Wei Qi; Gaurav Chopra; Christopher Adams; Yoko Kojima; Nicholas J Leeper; Xiumei Qu; Kathia Zaleta-Rivera; Kimihiko Kato; Yoshiji Yamada; Mitsutoshi Oguri; Allan Kuchinsky; Stanley L Hazen; J Wouter Jukema; Santhi K Ganesh; Elizabeth G Nabel; Keith Channon; Martin B Leon; Alain Charest; Thomas Quertermous; Euan A Ashley
Journal:  J Clin Invest       Date:  2014-11-17       Impact factor: 14.808

6.  Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study.

Authors:  Jeffrey J W Verschuren; Stella Trompet; Iris Postmus; M Lourdes Sampietro; Bastiaan T Heijmans; Jeanine J Houwing-Duistermaat; P Eline Slagboom; J Wouter Jukema
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

7.  Pathway analysis using genome-wide association study data for coronary restenosis--a potential role for the PARVB gene.

Authors:  Jeffrey J W Verschuren; Stella Trompet; M Lourdes Sampietro; Bastiaan T Heijmans; Werner Koch; Adnan Kastrati; Jeanine J Houwing-Duistermaat; P Eline Slagboom; Paul H A Quax; J Wouter Jukema
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

8.  Association of glutathione peroxidase-1 (GPx-1) rs1050450 Pro198Leu and Pro197Leu polymorphisms with cardiovascular risk: a meta-analysis of observational studies.

Authors:  Jun-Xia Zhang; Zhi-Mei Wang; Jun-Jie Zhang; Lin-Lin Zhu; Xiao-Fei Gao; Shao-Liang Chen
Journal:  J Geriatr Cardiol       Date:  2014-06       Impact factor: 3.327

9.  MnSOD and GPx1 polymorphism relationship with coronary heart disease risk and severity.

Authors:  Yosra Souiden; Hela Mallouli; Salah Meskhi; Yassine Chaabouni; Ahmed Rebai; Foued Chéour; Kacem Mahdouani
Journal:  Biol Res       Date:  2016-04-11       Impact factor: 5.612

10.  The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis.

Authors:  L Pleva; P Kovarova; L Faldynova; P Plevova; S Hilscherova; J Zapletalova; P Kusnierova; P Kukla
Journal:  BMC Cardiovasc Disord       Date:  2015-10-24       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.